<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0040">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Gdowski</surname>
    <given-names>AS</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ranjan</surname>
    <given-names>A</given-names>
   </name>, 
   <name name-style="western">
    <surname>Sarker</surname>
    <given-names>MR</given-names>
   </name>, 
   <etal>et al.</etal>
  </person-group> (
  <year>2017</year>). 
  <article-title>Bone-targeted cabazitaxel nanoparticles for metastatic prostate cancer skeletal lesions and pain</article-title>. 
  <source>Nanomedicine</source>
  <volume>12</volume>:
  <fpage>2083</fpage>–
  <lpage>95</lpage>.
  <pub-id pub-id-type="pmid">28805551</pub-id>
 </mixed-citation>
</ref>
